AC Immune (ACIU) Depreciation & Amortization (CF) (2015 - 2025)

AC Immune (ACIU) has reported Depreciation & Amortization (CF) for 12 consecutive years, with $411634.9 the latest figure, recorded in Q4 2025.

• In Q4 2025, Depreciation & Amortization (CF) changed 0.45% year-over-year to $411634.9; the TTM figure through Mar 2026 stood at $1.3 million (down 22.42% YoY), while the FY2025 annual figure was $1.7 million, down 0.89% from the prior year.
• Depreciation & Amortization (CF) retreated to $411634.9 in Q4 2025 per ACIU's latest filing, from $425037.2 in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $539118.9 in Q3 2021 and bottomed at $401522.4 in Q1 2025.
• Historically, Depreciation & Amortization (CF) has averaged $459036.8 across 5 years, with a median of $452536.6 in 2022.
• Annual changes were most pronounced in 2021 — Depreciation & Amortization (CF) surged 37.14% — and 2022, when it dropped 15.88%.
• AC Immune's Depreciation & Amortization (CF) stood at $527068.0 in 2021, then retreated by 9.01% to $479566.1 in 2022, then fell by 1.97% to $470106.8 in 2023, then retreated by 12.83% to $409806.3 in 2024, then climbed by 0.45% to $411634.9 in 2025.
• Business Quant data shows ACIU's Depreciation & Amortization (CF) at $411634.9 in Q4 2025, $425037.2 in Q3 2025, and $438464.2 in Q2 2025.